SMYD2 promotes cervical cancer growth by stimulating cell proliferation

SMYD2 promotes cervical cancer growth by stimulating cell proliferation

Abstract Background Cervical cancer is the most common gynecological malignancy with low terminal cure rate, and therefore new therapeutic targets are urgently needed to combat this disease. SMYD2, as an oncogene, is abnormal highly expressed in multiple types of tumors and further affects the occur...

Full description

Bibliographic Details
Main Authors: Jun-Jie Sun, Hong-Lin Li, Hui Ma, Yang Shi, Li-Rong Yin, Su-Jie Guo
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Cell & Bioscience
Subjects:
Cervical cancer
SMYD2
Prognosis
Proliferation
Therapeutic target
Online Access:http://link.springer.com/article/10.1186/s13578-019-0340-9

Internet

http://link.springer.com/article/10.1186/s13578-019-0340-9

Similar Items